Publication: Novel Oral Anticoagulants and Intracranial Hemorrhage
Novel Oral Anticoagulants and Intracranial Hemorrhage
Date
Date
Date
Citations
Keller, E., & Becker, K. J. (2018). Novel Oral Anticoagulants and Intracranial Hemorrhage. Stroke, 49(5), e174–e199. https://doi.org/10.1161/STROKEAHA.118.021380
Abstract
Abstract
Abstract
With the increasing use of novel oral anticoagulants (NOACs) or direct oral anticoagulants, vascular neurologists and neurocritical care providers are more commonly encountering situations in which decisions need to be made about either starting or reversing these medications. The most common clinical indication for the NOACs is atrial fibrillation, and the most dreaded complication of NOACs is intracranial hemorrhage (ICH). This brief review will summarize the data on the safety and efficacy of the NOACs, with an emphasis on ICH, as
Metrics
Downloads
Views
Additional indexing
Creators (Authors)
- Becker, Kyra J
Volume
Volume
Volume
Number
Number
Number
Page range/Item number
Page range/Item number
Page range/Item number
Page end
Page end
Page end
Item Type
Item Type
Item Type
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Language
Language
Language
Publication date
Publication date
Publication date
Date available
Date available
Date available
ISSN or e-ISSN
ISSN or e-ISSN
ISSN or e-ISSN
OA Status
OA Status
OA Status
Free Access at
Free Access at
Free Access at
Publisher DOI
Metrics
Downloads
Views
Citations
Keller, E., & Becker, K. J. (2018). Novel Oral Anticoagulants and Intracranial Hemorrhage. Stroke, 49(5), e174–e199. https://doi.org/10.1161/STROKEAHA.118.021380
